Roche recalls drug to reduce blood pressure

Article Abstract:

Posicor, the drug that lowers blood pressure, was pulled from the market in the US by its maker, Roche, because of too many potentially dangerous drug interactions. The product has been on the US market for 10 months and in that time there have been 24 deaths reported, mostly elderly patients with cardiovascular disease.The FDA reports about 400 interactions have been brought to the agency's attention. Roche has sent letters to healthcare givers and has a toll-free number for patients to call for more information.

Comment:

Hypertension medication Posicor taken off the market by Roche due to too many drug interaction problems

Product standards, safety, & recalls, Pharmaceutical Preparation Manufacturing, Legal/Government Regulation, Blood Pressure Preparations, Antihypertensive agents, Roche Holding AG

---

Novartis changes gene-therapy-management strategy

Article Abstract:

Novartis AG established numerous partnerships with small biotechnology companies during the 1990's. The company is now beginning a new stage of managing its gene-therapy strategy. Novartis will merge the majority of the units' operations into one management team. The team will be headed by Systemix Inc.'s CEO, Michael Perry. Systemix is an acquisition of Novartis. Downsizing administration duplication is expected to mean the elimination of 90 jobs.

Comment:

Beginning a new stage of managing its gene-therapy strategy

Strategy & planning, Chemicals & Allied Products, Chemical Manufacturing, Chemicals, Novartis AG

---

Ciba chairman injects a dose of U.S. style

Article Abstract:

Rolf Meyer, the chairman of Ciba Specialty Chemicals Inc., is implementing a dose of US-style corporate culture into the company. The move promises to shakeup Switzerland's reserved industrial establishment. Ciba has become one of the largest independent companies in an increasingly consolidated worldwide industry. Mr. Meyer will be introducing management ideas from the US into Ciba. US corporate culture tends to be more performance-oriented.

Comment:

Rolf Meyer, the chairman of Ciba Specialty Chemicals Inc., is utilizing a dose of US-style corporate culture into the company

Management dynamics, Basic Chemical Manufacturing, Specialty Chemicals, Company Personnel, Ciba Specialty Chemicals Inc.

Similar abstracts:

• Abstracts: Brisbane Broncos, brought to you by ... who's that? Sports management is a competitive game. Rafter's business stays in the family
• Abstracts: Firms face big losses as Asian cuts bite. Hybrid cars get ready for the green scene
• Abstracts: As long as you use tons of paper, buy a good printer. All-in-one machines for the office may not be the ones for all
• Abstracts: Barnes & Noble Web unit to go public. Amazon surge may reflect the new math of the Internet
• Abstracts: Zapata in deals to buy 21 Internet properties. Investment site co-founder is at home on the Internet. New owners of Byte suspend publication

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.